Radient Pharmaceuticals Corporation fka RXPC

[lakeshore555]

Dirt on MacLellan:

He was CEO for three companies that went into bankruptcy. His fellow BOD member in the last two of those, Boswell, just quit. His CFO in the first company that went bankrupt was Christianson, the new BOD member.

After becoming CEO of Radient, Radient's one asset that had value, Jade Pharma in China, broke all ties with Radient. The loss of Jade is what caused Radient's balance sheet to go from shareholder equity to shareholder deficit, which caused delisting and loan defaults.

After becoming CEO of Radient, he never did a private equity placement for Radient -- instead, he borrowed money, at increasingly usurious rates. Radient defaulted on EVERY ONE of those loans.

He gave guidance for $$$ millions in revenues and generated only 5% of guidance. To reward himself and his fellow officers for this performance, he handed out bonuses at Christmas.

All this can be easily verified by a little DD. Contrast these statements to statements of mergers and creeping takeovers that cannot be verified. Then, buy as much RXPC as you see fit.